← back to search

Michael S Saag

University of Alabama at Birmingham · US
Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV-related health complications and treatments, and HIV/AIDS drug development and treatment.
h-index
24
citations
8,123
works
60
NIH funding
primary concept
email

Recent publications

Multicenter study of heart failure phenotypes and physician-adjudicated causes in people with HIV
AIDS 2025cited by 2position: middledoi
Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study
Clinical Infectious Diseases 2023cited by 19position: middledoi
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
Clinical Infectious Diseases 2017cited by 91position: middledoi
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study
The Lancet HIV 2017cited by 15position: middledoi
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy
PLoS ONE 2016cited by 115position: middledoi
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals
JAIDS Journal of Acquired Immune Deficiency Syndromes 2015cited by 45position: middledoi
P99 Renal and bone safety of tenofovir alafenamide vs tenofovir disoproxil fumarate
Sexually Transmitted Infections 2015cited by 5position: middledoi
Impact of ART on Mortality in Cryptococcal Meningitis Patients: High-Income Settings
Bristol Research (University of Bristol) 2015cited by 4position: middle
Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients
Clinical Infectious Diseases 2014cited by 152position: middledoi
Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies
PLoS Medicine 2014cited by 151position: middledoi
Cumulative Viral Load Predicts All-Cause and AIDS-Related Mortality After Initiation of ART
Explore Bristol Research 2014cited by 1position: middle
Invasive Cervical Cancer Risk Among HIV-Infected Women
JAIDS Journal of Acquired Immune Deficiency Syndromes 2012cited by 229position: middledoi
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics
International Journal of Epidemiology 2012cited by 39position: middledoi

Grants

INCIDENCE, PREDICTORS, AND CLINICAL OUTCOMES OF SARS-CoV-2 INFECTION IN PERSONS WITH HIV
NIH3R24AI067039-15S1$186,5572021–2021Contact PIRePORTER
A Dynamic COVID-19 Community-Engaged Testing Strategy in Alabama (COVID COMET AL)
NIH3P30AI027767-32S1$3,323,5702020–2023Contact PIRePORTER
Core A Admin Core
NIH2P30AI027767-31$368,6792019–Contact PIRePORTER
UAB-MISS WIHS Cohort
NIH3U01AI103401-05S1$2,340,4682018–2019PIRePORTER
CFAR Network of Integrated Clinical Systems (CNICS)
NIH2R24AI067039-16$6,592,8622006–2026Contact PIRePORTER
CFAR Network of Integrated Clinical Systems (CNICS)
NIH5R24AI067039-17$6,416,9042006–2026Contact PIRePORTER
CFAR Network of Integrated Clinical Systems (CNICS)
NIH5R24AI067039-18$6,409,3122006–2026Contact PIRePORTER
CFAR Network of Integrated Clinical Systems (CNICS)
NIH5R24AI067039-19$6,404,1882006–2026Contact PIRePORTER
CFAR Network of Integrated Clinical Systems (CNICS)
NIH5R24AI067039-20$6,395,0382006–2026Contact PIRePORTER
Unsolicited R24 CFAR Network of Clinical Systems (CNICS)
NIH5R24AI067039-14$4,648,0452006–2021Contact PIRePORTER
Unsolicited R24 CFAR Network of Clinical Systems (CNICS)
NIH5R24AI067039-13$4,462,0052006–2021Contact PIRePORTER
Unsolicited R24 CFAR Network of Clinical Systems (CNICS)
NIH5R24AI067039-15$4,456,7082006–2021Contact PIRePORTER
Unsolicited R24 CFAR Network of Clinical Systems (CNICS)
NIH3R24AI067039-14S1$193,3652006–2021Contact PIRePORTER
UAB Center for AIDS Research (CFAR)
NIH5P30AI027767-32$3,055,7011997–2024Contact PIRePORTER
UAB Center for AIDS Research
NIH5P30AI027767-30$1,499,4091997–2019Contact PIRePORTER
Core A Admin Core
NIH5P30AI027767-33$1,236,3241997–2024Contact PIRePORTER
Core A Admin Core
NIH5P30AI027767-35$223,9441997–2024Contact PIRePORTER
Core A Admin Core
NIH3P30AI027767-35S1$213,6011997–2024Contact PIRePORTER

Frequent collaborators

Margaret May · University of Glasgow6 papers (2012–2016)Jonathan A C Sterne · University of Bristol6 papers (2012–2016)Suzanne M Ingle · University of Bristol6 papers (2012–2016)Heidi M. Crane · Seattle Pacific University5 papers (2012–2025)M. John Gill · Panjab University5 papers (2012–2016)Amy C. Justice · Yale University4 papers (2012–2016)Antonella d’Arminio Monforte · Check Point (Israel)4 papers (2012–2016)Jodie L. Guest · Emory University3 papers (2012–2015)Timothy R. Sterling · Vanderbilt University Medical Center3 papers (2014–2016)Peter Reiss · Amsterdam Neuroscience2 papers (2014–2014)Matthias Cavassini · University of Geneva2 papers (2014–2016)Ole Kirk · University of Copenhagen2 papers (2012–2015)Michael J. Mugavero · Department of Health Services2 papers (2014–2014)Jörg Janne Vehreschild · Goethe University Frankfurt2 papers (2012–2016)Fiona Lampe · London School of Hygiene & Tropical Medicine2 papers (2012–2016)Christian Manzardo · Universitat de Barcelona2 papers (2014–2015)Gerd Fätkenheuer · Janssen (United States)2 papers (2014–2014)Sophie Grabar · Université Claude Bernard Lyon 12 papers (2014–2016)Sophie Abgrall · Université Claude Bernard Lyon 12 papers (2014–2014) · 2 papers (2015–2016)